Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 171,100 shares at $232.19 ($39.2M) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $39.2M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $225.24 | 4,100 | $923K | 2.4% |
| 2 | $226.40 | 6,203 | $1.4M | 3.6% |
| 3 | $226.40 | 6,203 | $1.4M | 3.6% |
| 4 | $227.08 | 15,062 | $3.4M | 8.7% |
| 5 | $227.08 | 15,062 | $3.4M | 8.7% |
| 6 | $227.72 | 7,500 |
| $1.7M |
| 4.4% |
| 7 | $228.10 | 400 | $91K | 0.2% |
| 8 | $228.23 | 5,885 | $1.3M | 3.4% |
| 9 | $228.23 | 5,885 | $1.3M | 3.4% |
| 10 | $229.18 | 9,752 | $2.2M | 5.7% |
| 11 | $229.18 | 9,752 | $2.2M | 5.7% |
| 12 | $230.51 | 24,842 | $5.7M | 14.6% |
| 13 | $230.51 | 24,842 | $5.7M | 14.6% |
| 14 | $231.11 | 17,456 | $4.0M | 10.3% |
| 15 | $231.11 | 17,456 | $4.0M | 10.3% |
| 16 | $232.19 | 700 | $163K | 0.4% |
| Total | $229.17 avg | 171,100 | $39.2M | 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-10-07 | $7.5M | — | Filing → |